Protect your liver and promote optimal metabolic health | Alan Flanagan, PhD

Topics covered
Popular Clips
Episode Highlights
NAFLD Basics
Non-alcoholic fatty liver disease (NAFLD) is characterized by the accumulation of excess triglycerides in over 5% of liver cells, unrelated to alcohol consumption. explains that this condition is the most common cause of chronic liver disease, affecting approximately 25% of the global population 1. The prevalence varies significantly across different populations, influenced by factors such as sex and ethnicity. For instance, individuals of South and East Asian or Hispanic ancestry have a higher risk compared to those of Black or African American ancestry 1.
The diagnosis of non-alcoholic fatty liver disease is when there is an accumulation of excess triglyceride or excess fat in over 5% of hepatocytes or liver cells.
---
Understanding these demographic differences is crucial for identifying at-risk groups and tailoring preventive strategies.
Risk Factors
NAFLD affects about 25% of the population, with energy excess being a primary driver. highlights that chronic energy surplus leads to insulin resistance and elevated triglycerides, complicating the condition 2. Genetic and lifestyle factors, such as diet and physical inactivity, also play significant roles in risk levels. Ethnic and gender differences further influence susceptibility, with males generally at higher risk 3.
Current estimates, in terms of global estimates suggest, give or take, around 25% of the population may exhibit fatty liver.
---
Understanding these risk factors is essential for developing effective prevention and management strategies.
Diagnosis
Diagnosing NAFLD involves identifying excess triglycerides in liver cells, often through non-invasive methods like ultrasound or MRI. notes that symptoms can be subtle, making early detection challenging 1. The condition is closely linked with type 2 diabetes, though they can exist independently. The overlap between these conditions complicates diagnosis and management, as both share similar risk factors 4.
We have this term lipotoxicity, which is really characterizing all of that as an umbrella term for all of those factors that I was just describing.
---
Recognizing these connections is vital for accurate diagnosis and effective treatment plans.
Related Episodes


Protect Your Heart | Alan Flanagan, MSc
Answers 383 questions

Everything you need to know about metabolic health | Metabolic Health Masterclass
Answers 383 questions

Cholesterol, metabolic health and heart disease | Dr Alan Flanagan and Danny Lennon
Answers 383 questions

Is your liver full of fat? | Christos Mantzoros MD, DSc, PhD
Answers 383 questions
Addressing Gut Health Issues | Dr Alan Desmond
Answers 383 questions

Carnivore diet, veganism and nutrition misinformation | Dr Alan Flanagan
Answers 383 questions

Optimising your omega 3 intake | Dr Bill Harris
Answers 383 questions

Saturated fats, sugar and metabolic health | Richard Johnson, PhD
Answers 383 questions
The root cause of poor metabolic health | Simon Hill, Msc, Bsc
Answers 383 questions

Are lectins toxic? | Alan Flanagan, PhD & Matthew Nagra, Nd
Answers 383 questions

What you need to know about omega 3 and 6 fats | Philip Calder, PhD
Answers 383 questions
Evidence-based dietary fat tips | Simon Hill, Msc, Bsc
Answers 383 questions

Eating for cardiometabolic health | Andrea Glenn, PhD, RD
Answers 383 questions

Achieving Longevity and Healing through Food: A Deep Dive | Dr. Joel Fuhrman, Md
Answers 383 questions
